IGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM) 04784618190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2016-07-14 for IGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM) 04784618190 manufactured by Roche Diagnostics.

Event Text Entries

[49636833] (b)(6). This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[49636834] The sales representative indicated that the customer complained of erroneous results for 1 pregnant patient tested for igm antibodies to cytomegalovirus (cmv igm) and igg antibodies to cytomegalovirus (cmv igg). The date of event was not known. The erroneous results were reported outside of the laboratory. This medwatch will cover cmv igm. Refer to medwatch with (b)(6) for information on the cmv igg erroneous results. The initial cmv igm and cmv igg results from the e602 analyzer were negative. The actual results were not provided. The physician did not believe these results. The sample was sent to an external laboratory using the abbott method and the cmv igm and cmv igg results were positive. The actual results were not provided. No adverse event occurred. The e602 analyzer serial number was (b)(4). The customer provided additional cmv igm and igg results from (b)(6) 2016. The customer believes that these results show that seroconversion was not detectable on the e602 analyzer.
Patient Sequence No: 1, Text Type: D, B5


[55165755] A specific root cause could not be identified. Additional information was requested for investigation but was not provided. The customer submitted a sample from 06/14/2016 and the discrepant results were from a sample from 06/23/2016. The sample from 06/23/2016 was not available for investigation. The sample from 06/14/2016 was tested. The sample produced positive results for the elecsys cmv igm assay, the recomline cmv igm assay, the elecsys cmv igg assay and the recomline cmv igg assay. The elecsys cmv igg avidity results were low. The data indicate the patient had been recently infected with cmv. The sample from 06/14/2016 produced results that were comparable to the competitor system
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2016-00924
MDR Report Key5794810
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2016-07-14
Date of Report2016-09-12
Date of Event2016-06-23
Date Mfgr Received2016-06-23
Date Added to Maude2016-07-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameIGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM)
Generic NameENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Product CodeLFZ
Date Received2016-07-14
Model NumberNA
Catalog Number04784618190
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2016-07-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.